CLINICAL_TRIALS
trial_result
· 2014-07-31
Clinical Trial Update: An Open Label Study of Aripiprazole Intramuscular Injection in Subjects With Schizophrenia [Phase 1]
Summary
An open-label Phase 1 study evaluating intramuscular aripiprazole in individuals with schizophrenia has been completed, with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Otsuka Pharmaceutical Development & Commercialization, Inc. | Conditions: Schizophrenia | Phase 1 | Status: COMPLETED | Results posted: 2014-07-31